Diabetes and gut microbiota

doi:10.4239/wjd.v12.i10.1693

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8650)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

438

WORD

124

HTML

4449

Figures (1-2)

263

Sum=5274

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

421

Download

962

Sum=1383

Publishing Process of This Article

Item

Count

Browse

515

Download

1478

Sum=1993

Oct 15, 2021 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Oct 15, 2021; 12(10): 1693-1703
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1693

Full Size Figure Download Figure

Figure 2 The schematic mechanisms of metformin act through the gut microbiome and the related beneficial effects on diabetes. AMPK: AMP-activated protein kinase; FXR: farnesoid X receptor; GUDCA: glycoursodeoxycholic acid; SCFAs: short-chain fatty acids.

Citation: Xi Y, Xu PF. Diabetes and gut microbiota. World J Diabetes 2021; 12(10): 1693-1703
URL: https://www.wjgnet.com/1948-9358/full/v12/i10/1693.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i10.1693